About Us

About ICETCR 2026

The International Conference on Emerging Trends in Cancer Research (ICETCR 2026) is a landmark global event dedicated to advancing the frontiers of cancer science and care. Scheduled for April 8–10, 2026, in the culturally vibrant and scenic country of Thailand, this conference will convene a diverse community of oncology researchers, clinicians, healthcare professionals, industry leaders, policy makers, and early-career scientists from across the world.

Cancer remains one of the most formidable challenges in global health, demanding innovative solutions and interdisciplinary collaboration. ICETCR 2026 seeks to address this challenge by showcasing the latest breakthroughs and emerging trends across the entire spectrum of cancer research — from fundamental molecular biology to translational clinical applications.

Over three intensive days, participants will engage with cutting-edge topics such as:

• Novel molecular targets and pathways driving cancer progression
• Advances in immunotherapy and personalized medicine
• Innovations in early detection, diagnostic tools, and biomarkers
• Strategies for cancer prevention and public health initiatives
• Survivorship care and improving quality of life for patients
• Integration of artificial intelligence and digital health technologies in oncology

Program Features

The conference program features keynote presentations by world-renowned experts, plenary talks, focused symposia, interactive workshops, and poster sessions designed to foster active discussion and collaboration. Beyond the scientific agenda, ICETCR 2026 offers unique opportunities for networking, partnership building, and knowledge exchange — essential for accelerating research translation and improving patient outcomes globally.

Hosted in Thailand, a country celebrated for its rich cultural heritage and warm hospitality, the conference provides an inspiring setting to connect with peers, explore new ideas, and cultivate international collaborations.

Join us in Thailand and be part of a global movement dedicated to transforming cancer outcomes through science, collaboration, and innovation.